This is a potentially important finding because LAV is considered a sensitive predictor of outcomes in patients with cardiovascular disease and is an early marker of heart failure with preserved ejection fraction.26, 27, 28 We did not find a significant correlation between LV GLS (an emerging metric of cardiac function and prognosis) and big ET-1 within the patients with breast cancer. The gene discussed is EDN1; the disease is breast carcinoma.